Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer.
Saved in:
| Title: | Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer. |
|---|---|
| Authors: | Altman JE; Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, USA., Valentine A; Gregory W. Fulton ALS Center Barrow Neurological Institute, School of Life Sciences, Arizona State University, Phoenix, USA.; Department of Pathology, Virginia Commonwealth University, Richmond, USA., Dashti-Gibson N; Department of Pathology, Virginia Commonwealth University, Richmond, USA.; C. Kenneth and Diane Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, USA., Zboril EK; Department of Biochemistry, Virginia Commonwealth University, Richmond, USA., Boyd DC; Department of Pathology, Virginia Commonwealth University, Richmond, USA., Myrick RK; Department of Pathology, Virginia Commonwealth University, Richmond, USA., Olex AL; C. Kenneth and Diane Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, USA., Dozmorov MG; Department of Pathology, Virginia Commonwealth University, Richmond, USA.; Department of Biostatistics, Virginia Commonwealth University, Richmond, USA., Harrell JC; Department of Pathology, Virginia Commonwealth University, Richmond, USA. Joshua.harrell@VCUHEALTH.org.; Massey Comprehensive Cancer Center, Richmond, USA. Joshua.harrell@VCUHEALTH.org. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Feb 03; Vol. 45 (1). Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
